Central nervous system cavernous hemangioma (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Central nervous system cavernous hemangioma" in English language version.

refsWebsite

Global rank English rank

29nih.gov

4^th place

20doi.org

2^nd place

4semanticscholar.org

11^th place

8^th place

4worldcat.org

5^th place

3harvard.edu

18^th place

17^th place

doi.org

Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D (December 2009). "Cavernous malformations: natural history, diagnosis and treatment". Nature Reviews. Neurology. 5 (12): 659–670. doi:10.1038/nrneurol.2009.177. PMID 19953116. S2CID 11888726.
Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M, et al. (October 1999). "Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas". Nature Genetics. 23 (2): 189–193. doi:10.1038/13815. PMID 10508515. S2CID 22297740.
Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, Dokken CG, et al. (November 1999). "Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1)". Human Molecular Genetics. 8 (12): 2325–2333. doi:10.1093/hmg/8.12.2325. PMID 10545614.
Zawistowski JS, Serebriiskii IG, Lee MF, Golemis EA, Marchuk DA (February 2002). "KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis". Human Molecular Genetics. 11 (4): 389–396. doi:10.1093/hmg/11.4.389. PMID 11854171.
Petersen TA, Morrison LA, Schrader RM, Hart BL (February 2010). "Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype". AJNR. American Journal of Neuroradiology. 31 (2): 377–382. doi:10.3174/ajnr.A1822. PMC 4455949. PMID 19833796.
Gunel M, Awad IA, Finberg K, Anson JA, Steinberg GK, Batjer HH, et al. (April 1996). "A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans". The New England Journal of Medicine. 334 (15): 946–951. doi:10.1056/NEJM199604113341503. PMID 8596595.
Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, et al. (December 2003). "Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations". American Journal of Human Genetics. 73 (6): 1459–1464. doi:10.1086/380314. PMC 1180409. PMID 14624391.
Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, Johnson GL, Marchuk DA (September 2005). "CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis". Human Molecular Genetics. 14 (17): 2521–2531. doi:10.1093/hmg/ddi256. PMID 16037064.
Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, et al. (Société Française de Neurochirurgie) (January 2005). "Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations". American Journal of Human Genetics. 76 (1): 42–51. doi:10.1086/426952. PMC 1196432. PMID 15543491.
Liquori CL, Berg MJ, Squitieri F, Ottenbacher M, Sorlie M, Leedom TP, et al. (January 2006). "Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus". Human Mutation. 27 (1): 118. doi:10.1002/humu.9389. PMID 16329096. S2CID 30609244.
Castro M, Laviña B, Ando K, Álvarez-Aznar A, Abu Taha A, Brakebusch C, et al. (April 2019). "CDC42 Deletion Elicits Cerebral Vascular Malformations via Increased MEKK3-Dependent KLF4 Expression". Circulation Research. 124 (8): 1240–1252. doi:10.1161/CIRCRESAHA.118.314300. PMID 30732528.
Ren, Aileen A.; Snellings, Daniel A.; Su, Yourong S.; Hong, Courtney C.; Castro, Marco; Tang, Alan T.; Detter, Matthew R.; Hobson, Nicholas; Girard, Romuald; Romanos, Sharbel; Lightle, Rhonda; Moore, Thomas; Shenkar, Robert; Benavides, Christian; Beaman, M. Makenzie (2021-06-10). "PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism". Nature. 594 (7862): 271–276. Bibcode:2021Natur.594..271R. doi:10.1038/s41586-021-03562-8. ISSN 0028-0836. PMC 8626098. PMID 33910229.
Peyre, Matthieu; Miyagishima, Danielle; Bielle, Franck; Chapon, Françoise; Sierant, Michael; Venot, Quitterie; Lerond, Julie; Marijon, Pauline; Abi-Jaoude, Samiya; Le Van, Tuan; Labreche, Karim; Houlston, Richard; Faisant, Maxime; Clémenceau, Stéphane; Boch, Anne-Laure (2021-09-09). "Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations". New England Journal of Medicine. 385 (11): 996–1004. doi:10.1056/NEJMoa2100440. ISSN 0028-4793. PMC 8606022. PMID 34496175.
Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. (June 2013). "EndMT contributes to the onset and progression of cerebral cavernous malformations". Nature. 498 (7455): 492–496. Bibcode:2013Natur.498..492M. doi:10.1038/nature12207. PMID 23748444. S2CID 205234132.
Bravi L, Malinverno M, Pisati F, Rudini N, Cuttano R, Pallini R, et al. (March 2016). "Endothelial Cells Lining Sporadic Cerebral Cavernous Malformation Cavernomas Undergo Endothelial-to-Mesenchymal Transition". Stroke. 47 (3): 886–890. doi:10.1161/STROKEAHA.115.011867. PMID 26839352.
Malinverno, Matteo; Maderna, Claudio; Abu Taha, Abdallah; Corada, Monica; Orsenigo, Fabrizio; Valentino, Mariaelena; Pisati, Federica; Fusco, Carmela; Graziano, Paolo; Giannotta, Monica; Yu, Qing Cissy; Zeng, Yi Arial; Lampugnani, Maria Grazia; Magnusson, Peetra U.; Dejana, Elisabetta (2019-06-24). "Endothelial cell clonal expansion in the development of cerebral cavernous malformations". Nature Communications. 10 (1): 2761. Bibcode:2019NatCo..10.2761M. doi:10.1038/s41467-019-10707-x. ISSN 2041-1723. PMC 6591323. PMID 31235698.
Detter, Matthew R.; Snellings, Daniel A.; Marchuk, Douglas A. (2018-10-26). "Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells". Circulation Research. 123 (10): 1143–1151. doi:10.1161/CIRCRESAHA.118.313970. ISSN 0009-7330. PMC 6205520. PMID 30359189.
Globisch MA, Onyeogaziri FC, Smith RO, Arce M, Magnusson PU (October 2022). "Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations". International Journal of Molecular Sciences. 23 (20): 12575. doi:10.3390/ijms232012575. PMC 9604397. PMID 36293431.
Mouchtouris N, Chalouhi N, Chitale A, Starke RM, Tjoumakaris SI, Rosenwasser RH, Jabbour PM (2015). "Management of cerebral cavernous malformations: from diagnosis to treatment". TheScientificWorldJournal. 2015: 808314. doi:10.1155/2015/808314. PMC 4300037. PMID 25629087.
Rigamonti D, Hadley MN, Drayer BP, Johnson PC, Hoenig-Rigamonti K, Knight JT, Spetzler RF (August 1988). "Cerebral cavernous malformations. Incidence and familial occurrence". The New England Journal of Medicine. 319 (6): 343–347. doi:10.1056/NEJM198808113190605. PMID 3393196.

harvard.edu

ui.adsabs.harvard.edu

Ren, Aileen A.; Snellings, Daniel A.; Su, Yourong S.; Hong, Courtney C.; Castro, Marco; Tang, Alan T.; Detter, Matthew R.; Hobson, Nicholas; Girard, Romuald; Romanos, Sharbel; Lightle, Rhonda; Moore, Thomas; Shenkar, Robert; Benavides, Christian; Beaman, M. Makenzie (2021-06-10). "PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism". Nature. 594 (7862): 271–276. Bibcode:2021Natur.594..271R. doi:10.1038/s41586-021-03562-8. ISSN 0028-0836. PMC 8626098. PMID 33910229.
Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. (June 2013). "EndMT contributes to the onset and progression of cerebral cavernous malformations". Nature. 498 (7455): 492–496. Bibcode:2013Natur.498..492M. doi:10.1038/nature12207. PMID 23748444. S2CID 205234132.
Malinverno, Matteo; Maderna, Claudio; Abu Taha, Abdallah; Corada, Monica; Orsenigo, Fabrizio; Valentino, Mariaelena; Pisati, Federica; Fusco, Carmela; Graziano, Paolo; Giannotta, Monica; Yu, Qing Cissy; Zeng, Yi Arial; Lampugnani, Maria Grazia; Magnusson, Peetra U.; Dejana, Elisabetta (2019-06-24). "Endothelial cell clonal expansion in the development of cerebral cavernous malformations". Nature Communications. 10 (1): 2761. Bibcode:2019NatCo..10.2761M. doi:10.1038/s41467-019-10707-x. ISSN 2041-1723. PMC 6591323. PMID 31235698.

nih.gov

pubmed.ncbi.nlm.nih.gov

Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D (December 2009). "Cavernous malformations: natural history, diagnosis and treatment". Nature Reviews. Neurology. 5 (12): 659–670. doi:10.1038/nrneurol.2009.177. PMID 19953116. S2CID 11888726.
Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M, et al. (October 1999). "Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas". Nature Genetics. 23 (2): 189–193. doi:10.1038/13815. PMID 10508515. S2CID 22297740.
Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, Dokken CG, et al. (November 1999). "Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1)". Human Molecular Genetics. 8 (12): 2325–2333. doi:10.1093/hmg/8.12.2325. PMID 10545614.
Zawistowski JS, Serebriiskii IG, Lee MF, Golemis EA, Marchuk DA (February 2002). "KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis". Human Molecular Genetics. 11 (4): 389–396. doi:10.1093/hmg/11.4.389. PMID 11854171.
Petersen TA, Morrison LA, Schrader RM, Hart BL (February 2010). "Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype". AJNR. American Journal of Neuroradiology. 31 (2): 377–382. doi:10.3174/ajnr.A1822. PMC 4455949. PMID 19833796.
Gunel M, Awad IA, Finberg K, Anson JA, Steinberg GK, Batjer HH, et al. (April 1996). "A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans". The New England Journal of Medicine. 334 (15): 946–951. doi:10.1056/NEJM199604113341503. PMID 8596595.
Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, et al. (December 2003). "Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations". American Journal of Human Genetics. 73 (6): 1459–1464. doi:10.1086/380314. PMC 1180409. PMID 14624391.
Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, Johnson GL, Marchuk DA (September 2005). "CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis". Human Molecular Genetics. 14 (17): 2521–2531. doi:10.1093/hmg/ddi256. PMID 16037064.
Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, et al. (Société Française de Neurochirurgie) (January 2005). "Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations". American Journal of Human Genetics. 76 (1): 42–51. doi:10.1086/426952. PMC 1196432. PMID 15543491.
Liquori CL, Berg MJ, Squitieri F, Ottenbacher M, Sorlie M, Leedom TP, et al. (January 2006). "Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus". Human Mutation. 27 (1): 118. doi:10.1002/humu.9389. PMID 16329096. S2CID 30609244.
Castro M, Laviña B, Ando K, Álvarez-Aznar A, Abu Taha A, Brakebusch C, et al. (April 2019). "CDC42 Deletion Elicits Cerebral Vascular Malformations via Increased MEKK3-Dependent KLF4 Expression". Circulation Research. 124 (8): 1240–1252. doi:10.1161/CIRCRESAHA.118.314300. PMID 30732528.
Ren, Aileen A.; Snellings, Daniel A.; Su, Yourong S.; Hong, Courtney C.; Castro, Marco; Tang, Alan T.; Detter, Matthew R.; Hobson, Nicholas; Girard, Romuald; Romanos, Sharbel; Lightle, Rhonda; Moore, Thomas; Shenkar, Robert; Benavides, Christian; Beaman, M. Makenzie (2021-06-10). "PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism". Nature. 594 (7862): 271–276. Bibcode:2021Natur.594..271R. doi:10.1038/s41586-021-03562-8. ISSN 0028-0836. PMC 8626098. PMID 33910229.
Peyre, Matthieu; Miyagishima, Danielle; Bielle, Franck; Chapon, Françoise; Sierant, Michael; Venot, Quitterie; Lerond, Julie; Marijon, Pauline; Abi-Jaoude, Samiya; Le Van, Tuan; Labreche, Karim; Houlston, Richard; Faisant, Maxime; Clémenceau, Stéphane; Boch, Anne-Laure (2021-09-09). "Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations". New England Journal of Medicine. 385 (11): 996–1004. doi:10.1056/NEJMoa2100440. ISSN 0028-4793. PMC 8606022. PMID 34496175.
Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. (June 2013). "EndMT contributes to the onset and progression of cerebral cavernous malformations". Nature. 498 (7455): 492–496. Bibcode:2013Natur.498..492M. doi:10.1038/nature12207. PMID 23748444. S2CID 205234132.
Bravi L, Malinverno M, Pisati F, Rudini N, Cuttano R, Pallini R, et al. (March 2016). "Endothelial Cells Lining Sporadic Cerebral Cavernous Malformation Cavernomas Undergo Endothelial-to-Mesenchymal Transition". Stroke. 47 (3): 886–890. doi:10.1161/STROKEAHA.115.011867. PMID 26839352.
Malinverno, Matteo; Maderna, Claudio; Abu Taha, Abdallah; Corada, Monica; Orsenigo, Fabrizio; Valentino, Mariaelena; Pisati, Federica; Fusco, Carmela; Graziano, Paolo; Giannotta, Monica; Yu, Qing Cissy; Zeng, Yi Arial; Lampugnani, Maria Grazia; Magnusson, Peetra U.; Dejana, Elisabetta (2019-06-24). "Endothelial cell clonal expansion in the development of cerebral cavernous malformations". Nature Communications. 10 (1): 2761. Bibcode:2019NatCo..10.2761M. doi:10.1038/s41467-019-10707-x. ISSN 2041-1723. PMC 6591323. PMID 31235698.
Detter, Matthew R.; Snellings, Daniel A.; Marchuk, Douglas A. (2018-10-26). "Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells". Circulation Research. 123 (10): 1143–1151. doi:10.1161/CIRCRESAHA.118.313970. ISSN 0009-7330. PMC 6205520. PMID 30359189.
Globisch MA, Onyeogaziri FC, Smith RO, Arce M, Magnusson PU (October 2022). "Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations". International Journal of Molecular Sciences. 23 (20): 12575. doi:10.3390/ijms232012575. PMC 9604397. PMID 36293431.
Mouchtouris N, Chalouhi N, Chitale A, Starke RM, Tjoumakaris SI, Rosenwasser RH, Jabbour PM (2015). "Management of cerebral cavernous malformations: from diagnosis to treatment". TheScientificWorldJournal. 2015: 808314. doi:10.1155/2015/808314. PMC 4300037. PMID 25629087.
Rigamonti D, Hadley MN, Drayer BP, Johnson PC, Hoenig-Rigamonti K, Knight JT, Spetzler RF (August 1988). "Cerebral cavernous malformations. Incidence and familial occurrence". The New England Journal of Medicine. 319 (6): 343–347. doi:10.1056/NEJM198808113190605. PMID 3393196.

ncbi.nlm.nih.gov

Petersen TA, Morrison LA, Schrader RM, Hart BL (February 2010). "Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype". AJNR. American Journal of Neuroradiology. 31 (2): 377–382. doi:10.3174/ajnr.A1822. PMC 4455949. PMID 19833796.
Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, et al. (December 2003). "Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations". American Journal of Human Genetics. 73 (6): 1459–1464. doi:10.1086/380314. PMC 1180409. PMID 14624391.
Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, et al. (Société Française de Neurochirurgie) (January 2005). "Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations". American Journal of Human Genetics. 76 (1): 42–51. doi:10.1086/426952. PMC 1196432. PMID 15543491.
Ren, Aileen A.; Snellings, Daniel A.; Su, Yourong S.; Hong, Courtney C.; Castro, Marco; Tang, Alan T.; Detter, Matthew R.; Hobson, Nicholas; Girard, Romuald; Romanos, Sharbel; Lightle, Rhonda; Moore, Thomas; Shenkar, Robert; Benavides, Christian; Beaman, M. Makenzie (2021-06-10). "PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism". Nature. 594 (7862): 271–276. Bibcode:2021Natur.594..271R. doi:10.1038/s41586-021-03562-8. ISSN 0028-0836. PMC 8626098. PMID 33910229.
Peyre, Matthieu; Miyagishima, Danielle; Bielle, Franck; Chapon, Françoise; Sierant, Michael; Venot, Quitterie; Lerond, Julie; Marijon, Pauline; Abi-Jaoude, Samiya; Le Van, Tuan; Labreche, Karim; Houlston, Richard; Faisant, Maxime; Clémenceau, Stéphane; Boch, Anne-Laure (2021-09-09). "Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations". New England Journal of Medicine. 385 (11): 996–1004. doi:10.1056/NEJMoa2100440. ISSN 0028-4793. PMC 8606022. PMID 34496175.
Malinverno, Matteo; Maderna, Claudio; Abu Taha, Abdallah; Corada, Monica; Orsenigo, Fabrizio; Valentino, Mariaelena; Pisati, Federica; Fusco, Carmela; Graziano, Paolo; Giannotta, Monica; Yu, Qing Cissy; Zeng, Yi Arial; Lampugnani, Maria Grazia; Magnusson, Peetra U.; Dejana, Elisabetta (2019-06-24). "Endothelial cell clonal expansion in the development of cerebral cavernous malformations". Nature Communications. 10 (1): 2761. Bibcode:2019NatCo..10.2761M. doi:10.1038/s41467-019-10707-x. ISSN 2041-1723. PMC 6591323. PMID 31235698.
Detter, Matthew R.; Snellings, Daniel A.; Marchuk, Douglas A. (2018-10-26). "Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells". Circulation Research. 123 (10): 1143–1151. doi:10.1161/CIRCRESAHA.118.313970. ISSN 0009-7330. PMC 6205520. PMID 30359189.
Globisch MA, Onyeogaziri FC, Smith RO, Arce M, Magnusson PU (October 2022). "Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations". International Journal of Molecular Sciences. 23 (20): 12575. doi:10.3390/ijms232012575. PMC 9604397. PMID 36293431.
Mouchtouris N, Chalouhi N, Chitale A, Starke RM, Tjoumakaris SI, Rosenwasser RH, Jabbour PM (2015). "Management of cerebral cavernous malformations: from diagnosis to treatment". TheScientificWorldJournal. 2015: 808314. doi:10.1155/2015/808314. PMC 4300037. PMID 25629087.

semanticscholar.org

api.semanticscholar.org

Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D (December 2009). "Cavernous malformations: natural history, diagnosis and treatment". Nature Reviews. Neurology. 5 (12): 659–670. doi:10.1038/nrneurol.2009.177. PMID 19953116. S2CID 11888726.
Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M, et al. (October 1999). "Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas". Nature Genetics. 23 (2): 189–193. doi:10.1038/13815. PMID 10508515. S2CID 22297740.
Liquori CL, Berg MJ, Squitieri F, Ottenbacher M, Sorlie M, Leedom TP, et al. (January 2006). "Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus". Human Mutation. 27 (1): 118. doi:10.1002/humu.9389. PMID 16329096. S2CID 30609244.
Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. (June 2013). "EndMT contributes to the onset and progression of cerebral cavernous malformations". Nature. 498 (7455): 492–496. Bibcode:2013Natur.498..492M. doi:10.1038/nature12207. PMID 23748444. S2CID 205234132.

worldcat.org

Ren, Aileen A.; Snellings, Daniel A.; Su, Yourong S.; Hong, Courtney C.; Castro, Marco; Tang, Alan T.; Detter, Matthew R.; Hobson, Nicholas; Girard, Romuald; Romanos, Sharbel; Lightle, Rhonda; Moore, Thomas; Shenkar, Robert; Benavides, Christian; Beaman, M. Makenzie (2021-06-10). "PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism". Nature. 594 (7862): 271–276. Bibcode:2021Natur.594..271R. doi:10.1038/s41586-021-03562-8. ISSN 0028-0836. PMC 8626098. PMID 33910229.
Peyre, Matthieu; Miyagishima, Danielle; Bielle, Franck; Chapon, Françoise; Sierant, Michael; Venot, Quitterie; Lerond, Julie; Marijon, Pauline; Abi-Jaoude, Samiya; Le Van, Tuan; Labreche, Karim; Houlston, Richard; Faisant, Maxime; Clémenceau, Stéphane; Boch, Anne-Laure (2021-09-09). "Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations". New England Journal of Medicine. 385 (11): 996–1004. doi:10.1056/NEJMoa2100440. ISSN 0028-4793. PMC 8606022. PMID 34496175.
Malinverno, Matteo; Maderna, Claudio; Abu Taha, Abdallah; Corada, Monica; Orsenigo, Fabrizio; Valentino, Mariaelena; Pisati, Federica; Fusco, Carmela; Graziano, Paolo; Giannotta, Monica; Yu, Qing Cissy; Zeng, Yi Arial; Lampugnani, Maria Grazia; Magnusson, Peetra U.; Dejana, Elisabetta (2019-06-24). "Endothelial cell clonal expansion in the development of cerebral cavernous malformations". Nature Communications. 10 (1): 2761. Bibcode:2019NatCo..10.2761M. doi:10.1038/s41467-019-10707-x. ISSN 2041-1723. PMC 6591323. PMID 31235698.
Detter, Matthew R.; Snellings, Daniel A.; Marchuk, Douglas A. (2018-10-26). "Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells". Circulation Research. 123 (10): 1143–1151. doi:10.1161/CIRCRESAHA.118.313970. ISSN 0009-7330. PMC 6205520. PMID 30359189.